Gujarat Fluorochemicals Q1 FY27: Strong chemicals quarter, battery materials still in build-out

Gujarat Fluorochemicals Limited reported a strong start to FY27, led by broad-based growth in its core chemical businesses. In Q1 FY27, consolidated revenue from operations rose to INR 1,588 crore, up 24% year on year, while consolidated EBITDA increased 24% to INR 428 crore. Consolidated profit after tax (PAT) stood at INR 219 crore, up 20% year on year.

The chemical segment remained the primary driver. Chemical segment revenue came in at INR 1,574 crore, up 23% year on year, while chemical segment EBITDA rose 29% to INR 458 crore. Management attributed the performance largely to R32 refrigerants and fluoropolymers, along with improving product mix and operating leverage.

A quarter powered by fluoropolymers and R32

Within the chemicals portfolio, fluoropolymers continued to deliver steady growth despite what the company described as a challenging global environment. Fluoropolymers revenue in Q1 FY27 was INR 914 crore, up 15% year on year and 8% sequentially. The company highlighted that a higher-value product mix and volume improvement supported performance, with demand linked to new-age applications such as semiconductors, data centres, automotive, and green hydrogen.

Fluorochemicals delivered the strongest growth among verticals. Revenue rose to INR 458 crore, up 52% year on year and 44% quarter on quarter. Management said this was driven primarily by R32 refrigerant sales, along with healthy growth across the broader refrigerant portfolio.

Bulk chemicals remained stable. Revenue increased to INR 164 crore, up 11% year on year, with the company attributing performance largely to improved realizations. The outlook commentary suggested stability in caustic soda demand in FY27, while chloromethanes were expected to remain range bound.

Financial snapshot

The company also highlighted improved efficiency metrics. ROCE improved to 16.63% in Q1 FY27 versus 14.05% in FY26, and ROE improved to 15.18% versus 12.17% in FY26. Working capital days reduced to 149 days from 192 days in March 2026.

Refrigerants: capacity additions and a broader bouquet

A key theme in the call was expanding refrigerants capacity and product breadth. Management said existing R32 utilization is at peak and reiterated that an R32 capacity expansion is expected to be commissioned in Q2 FY27. It also stated it expects full utilization once additional capacity is available.

The company is also adding R134a to the refrigerants portfolio. Management said the R134a project is on track and expected to be commissioned within FY27, with an internal target earlier than the end of the year. In response to questions, it clarified that the R134a project is a brownfield expansion at an existing site.

On sourcing, management said trichloroethylene required for R134a would be imported, with suppliers identified, and the company does not see this as a constraint.

The strategic logic presented by management is that a more complete refrigerants product set strengthens customer relevance and helps the company leverage its long-standing global brand and marketing network. It also indicated a specific advantage in being able to offer both R32 and R125, which allows participation in R410 blends.

Fluoropolymers: mix upgrade, approvals, and incremental debottlenecking

In fluoropolymers, management emphasized that growth is being driven more by moving up the value chain than by competing purely on commodity pricing. On pricing, executives indicated the company takes small, formula-based or customer-agreed price corrections to address input cost volatility and protect margins, rather than relying on broad price hikes.

A recurring discussion point was customer approvals for high-end grades. Management described approvals as a key gating factor in scaling niche fluoropolymer volumes. It indicated that approvals are progressing and that most approvals should be in place by the end of FY27, with volumes expected to increase in the second half.

On capacity, management did not provide product-wise expansion detail, but it did describe debottlenecking as a continuous process undertaken to balance capacities as utilization rises.

Battery materials: early revenues, continued losses, and a guided ramp-up

Battery materials remained the weak spot in near-term profitability but is central to the company’s longer-term narrative. In Q1 FY27, battery materials revenue was INR 14 crore, while EBITDA was negative INR 30 crore and PAT was negative INR 42 crore.

Operationally, management positioned the business as being in qualification and commercialization mode.

LiPF6 was described as the most advanced, with both capacity expansion and customer commercialization progressing with leading global electrolyte manufacturers. Electrolyte qualification and sampling with Indian cell manufacturers were stated to be progressing with audits and plant visits. Across LFP cathode active materials and PVDF binders, management said the focus is on consistency, customer qualification and commercial scale-up.

Importantly, management offered time-linked expectations. It said significant revenue traction is expected toward the end of this financial year and in FY28. It also stated it is on track for three-digit quarterly revenue by Q4 and a significant ramp-up in FY28.

Capital allocation and project re-prioritisation

The presentation indicates a step-up in planned capex. FY27 planned capex is shown at INR 3,100 crore, split as INR 800 crore for GFL and INR 2,300 crore for the EV business.

A notable change discussed on the call was the Oman battery materials project. Management said the Oman project has been put on hold, and the planned capex is being shifted to India to execute faster and meet customer commitments, citing geopolitical reasons and delays.

It also clarified that the earlier referenced sovereign funding linked to the Oman project would not be available for the India relocation, but said fundraising is ongoing and funding is not expected to be a constraint for capacity additions.

Takeaways from Q1 FY27

Gujarat Fluorochemicals entered FY27 with strong momentum in its established chemicals businesses. Fluoropolymers and fluorochemicals drove growth, while improved operating leverage supported margins. Refrigerants remain a key earnings lever, with R32 capacity expansion expected in Q2 FY27 and R134a targeted within FY27.

At the same time, the battery materials business remains in an investment phase with losses in Q1, though management signalled that qualification milestones are translating into an expected revenue ramp-up by the end of FY27 and into FY28. The larger FY27 capex plan and the decision to move the Oman project to India will be key execution items to track through the year.